Check out the Annual Meeting schedule.

The only full, up-to-date ASGCT Annual Meeting program

All events take place at the Los Angeles Convention Center unless otherwise noted.


Abstracts Career Fair Schedule at a Glance Full Program PDF

The schedule below is an often-updated, live reflection of the 26th Annual Meeting program. Sessions, talks, and speaker information will be added as it is confirmed. Abstract sessions will be added to the schedule starting in early April.

Filter by session types, or search by speaker, title, or keyword. Learn more.

Last update: 5/17/23


Synthetic/Molecular Conjugates and Physical Methods for Delivery of Gene Therapeutics I has been moved to Room 411

AAV Vectors: Clinical and Non-Human Primate Studies has been moved to Petree Hall C

Annual Meeting Hours

  • Tuesday, May 16
    7 a.m. - 7 p.m.
  • Wednesday, May 17
    7 a.m. - 7 p.m.
  • Thursday, May 18
    7 a.m. - 7 p.m.
  • Friday, May 19
    7 a.m. - 7 p.m.
  • Saturday, May 20
    7 a.m. - noon



How to Become a Site for AAV Gene Therapy Trials

This workshop is designed to outline the steps needed to become a site for AAV gene therapy trials a...

Accessibility of Gene Therapies: Exploring the Continuum from Patient-Specific to Market Approved Therapies

The advent of recently translated technologies, including antisense oligonucleotides and CRISPR-medi...

The Magic Year - Founders Tips for What to do in Your Last Six Months in Academia and First Six Months in Industry

Spinning a company straight out of academia can be a daunting task for first-time technical founders...

Precise Genome Editing: One Goal, Multiple Avenues

Decades of refinements have made precision gene editing a clinical reality. In this workshop, our sp...

Immune Effector Cells: 2023 and Beyond!

With the goals of reflecting on the advances made over the past decade in adoptive cell therapy (ACT...

AAV Capsid Biology

AAV Vectors - Product Development Manufacturing: Downstream

Pricing Considerations in Genetic Therapies - Reassessing Access and Privilege

The advent of fully commercialized gene and cell therapies in the last decade has prompted debates a...